Skip to main content
. 2015 Jul 16;119(6):604–616. doi: 10.1152/japplphysiol.00317.2015

Table 3.

ET-1 signaling IPA canonical pathway

Symbol GeneID DFA.OE DFA.OI D2a.OE D2a.OI
Shc1 85385 0.813 0.608* 0.808 0.869
Fos 314322 0.346* 0.325* 0.976 0.983
Pla2 g5 29354 1.352* 1.626* 0.895 1.163
Prkcz 25522 0.684 0.352* 2.042* 1.381
Prdx6 94167 1.517* 1.476* 1.188 1.082
Casq1 686019 0.535 1.112 0.664 1.221
Plcd1 24655 0.907 1.011 0.935 0.95
Pla2 g16 24913 1.513* 1.12 1.014 1.084
Myc 24577 1.162 0.957 1.506* 0.962
Adcy4 54223 0.859 0.845 1.069 1.081
Pik3r6 497932 1.032 1.036 1.28 0.848
Pld4 362792 0.999 0.766* 1.32 0.903
Pdia3 29468 1.304 1.568* 0.775 0.906
Mapk6 58840 0.633* 0.698* 0.645* 0.997
Gnat1 363143 1.113 0.796 1.226 1.002
Ece1 94204 0.674 0.67 0.903 0.941

Results of IPA analysis to evaluate the effects of EX and SPRINT on expression of genes in this IPA Canonical pathway. Results are expressed as fold change for the EX (OE) or SPRINT (OI) values relative to that of the sedentary OLETF value for that sample. Thus any entry that is >1.00 (italic font) reflects a gene with increased expression and any entry that is <1.00 (nonitalic font) reflects a gene with decreased expression. The * indicate a value that is significantly changed relative to sedentary OLETF rats (P < 0.01). The Symbol and Gene IDs are from the National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/) gene bank and defined therein.

HHS Vulnerability Disclosure